PMID- 34632841
OWN - NLM
STAT- MEDLINE
DCOM- 20211012
LR  - 20230921
IS  - 1473-2300 (Electronic)
IS  - 0300-0605 (Print)
IS  - 0300-0605 (Linking)
VI  - 49
IP  - 10
DP  - 2021 Oct
TI  - Glycemic control and its association with sociodemographics, comorbid conditions, 
      and medication adherence among patients with type 2 diabetes in southwestern 
      Nigeria.
PG  - 3000605211044040
LID - 10.1177/03000605211044040 [doi]
LID - 03000605211044040
AB  - OBJECTIVE: We determined the prevalence of poor glycemic control and associations 
      with sociodemographics, comorbid conditions, and medication adherence among 
      patients with type 2 diabetes mellitus (T2DM) at a tertiary hospital in 
      southwestern Nigeria. METHODS: We conducted a retrospective observational study 
      among 300 patients with T2DM using systematic random sampling. We used a 
      semi-structured questionnaire to collect information on respondents' 
      sociodemographic profile, lifestyle, comorbid conditions, and antidiabetic 
      medications. Adherence was determined using the Morisky Medication Adherence 
      Scale. Fasting blood samples were tested using a glycated hemoglobin marker. 
      Multivariate logistic regression was used to identify factors associated with 
      poor glycemic control. RESULTS: Respondents' mean age was 61.9 +/- 11.8 years. The 
      prevalence of poor glycemic control was 40.0% (95% confidence interval [CI]: 
      34.4%-45.8%). The adjusted odds ratio (95% CI) for factors associated with poor 
      glycemic control was 2.522 (1.402-4.647) for older age, 1.882 (1.021-3.467) for 
      low income, 1.734 (1.013-3.401) for obesity, 2.014 (1.269-5.336) for 
      non-initiation of insulin therapy, and 1.830 (1.045-3.206) for poor medication 
      adherence. CONCLUSION: Older age, lower income, obesity, non-initiation of 
      insulin, and poor medication adherence were associated with poor glycemic 
      control. These variables may help clinicians identify patients at high risk of 
      poor glycemic control.
FAU - Ibrahim, Azeez Oyemomi
AU  - Ibrahim AO
AUID- ORCID: 0000-0002-2395-9551
AD  - Department of Family Medicine, Federal Teaching Hospital, Ido Ekiti, Nigeria.
FAU - Agboola, Segun Mattew
AU  - Agboola SM
AD  - Department of Family Medicine, 470822Afe Babalola University, Afe Babalola 
      University, Ado Ekiti, Nigeria.
FAU - Elegbede, Olayide Toyin
AU  - Elegbede OT
AD  - Department of Family Medicine, 470822Afe Babalola University, Afe Babalola 
      University, Ado Ekiti, Nigeria.
FAU - Ismail, Waheed Olalekan
AU  - Ismail WO
AD  - Department of Family Medicine, Obafemi Awolowo University Teaching Hospital, 
      Ile-Ife, Nigeria.
FAU - Agbesanwa, Tosin Anthony
AU  - Agbesanwa TA
AD  - Department of Family Medicine, Ekiti State University Teaching Hospital, Ado 
      Ekiti, Nigeria.
FAU - Omolayo, Taiwo Amos
AU  - Omolayo TA
AD  - Department of Family Medicine, Federal Teaching Hospital, Ido Ekiti, Nigeria.
LA  - eng
PT  - Journal Article
PT  - Observational Study
PL  - England
TA  - J Int Med Res
JT  - The Journal of international medical research
JID - 0346411
RN  - 0 (Blood Glucose)
SB  - IM
MH  - Aged
MH  - Blood Glucose
MH  - *Diabetes Mellitus, Type 2/drug therapy/epidemiology
MH  - Glycemic Control
MH  - Humans
MH  - Medication Adherence
MH  - Middle Aged
MH  - Nigeria
PMC - PMC8504241
OTO - NOTNLM
OT  - Ido Ekiti
OT  - Predictor
OT  - glycemic control
OT  - risk factor
OT  - rural Nigeria
OT  - type 2 diabetes
COIS- Declaration of conflicting interest: The authors declare that they have no 
      conflicts of interest.
EDAT- 2021/10/12 06:00
MHDA- 2021/10/13 06:00
PMCR- 2021/10/09
CRDT- 2021/10/11 08:43
PHST- 2021/10/11 08:43 [entrez]
PHST- 2021/10/12 06:00 [pubmed]
PHST- 2021/10/13 06:00 [medline]
PHST- 2021/10/09 00:00 [pmc-release]
AID - 10.1177_03000605211044040 [pii]
AID - 10.1177/03000605211044040 [doi]
PST - ppublish
SO  - J Int Med Res. 2021 Oct;49(10):3000605211044040. doi: 10.1177/03000605211044040.